Gonadorelin vs Sermorelin
A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Gonadorelin
Synthetic form of endogenous gonadotropin-releasing hormone (GnRH) that stimulates LH and FSH release from the anterior pituitary. Used in TRT protocols to maintain testicular function and prevent atrophy during exogenous testosterone administration. Preserves spermatogenesis and endogenous testosterone production capacity.
Full profileSermorelin
Sermorelin is a synthetic analog of the first 29 amino acids of GHRH (Growth Hormone-Releasing Hormone). It was FDA-approved for pediatric GH deficiency diagnosis and is widely used off-label in anti-aging and performance medicine. It stimulates pulsatile GH release more physiologically than exogenous GH.
Full profile| Gonadorelin | Sermorelin | |
|---|---|---|
| Category | Performance & Growth Hormone | Performance & Growth Hormone |
| Also known as | GnRH, gonadotropin-releasing hormone, Factrel, Lutrepulse | GHRH 1-29, GRF 1-29 NH2, Geref |
| Evidence | Research-stage | FDA-approved |
| Dosing range | 50mcg–200mcg mcg, 2–3x per week subcutaneous | 100mcg–500mcg mcg, once daily (before sleep) |
| Administration | Subcutaneous injection, Intranasal (pulsatile delivery) | Subcutaneous injection |
| Key side effects | Injection site reactions, Headache, Nausea, Flushing | Injection site redness, Headache, Flushing, Dizziness |
| Cited sources | 2 references | 1 reference |
Key differences
- Evidence level differs: Gonadorelin is research-stage, while Sermorelin is fda-approved.
- Administration: Gonadorelin — Subcutaneous injection, Intranasal (pulsatile delivery); Sermorelin — Subcutaneous injection.
- Frequency: Gonadorelin is typically 2–3x per week subcutaneous; Sermorelin is once daily (before sleep).
- Research depth: this profile cites 2 sources for Gonadorelin vs 1 for Sermorelin.
How each works
Gonadorelin
Gonadorelin directly binds GnRH receptors in the anterior pituitary to trigger LH and FSH secretion, which in turn stimulates Leydig cells for testosterone production and maintains spermatogenesis. Used as a TRT adjunct, pulsatile gonadorelin administration mimics natural hypothalamic GnRH to prevent testicular suppression associated with exogenous androgen use.
Sermorelin
Sermorelin works by binding pituitary GHRH receptors to stimulate GH secretion within the body's natural feedback loop. Unlike synthetic GH, it does not suppress endogenous production. Clinical studies show improved body composition, sleep quality, and IGF-1 levels in GH-deficient adults. Its short half-life (~10 min) means it requires daily dosing.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.